Kushner, lead author of the study and an obesity researcher at Northwestern University Feinberg School of Medicine who works with Novo Nordisk, called the drug a "game-changer" in an interview with The New York Times
Discussion The global diabetes epidemic, affecting approximately 828 million adults in 2022 32 , has driven widespread adoption of GLP-1 RAs due to their dual glycemic and weight management benefits 33,34,35
The people I have seen get the best long-term outcomes were rarely the most intense
They are taken once a day and have been found to be effective for weight loss
The additional GIP receptor activation in Retatrutide contributes to its higher weight loss efficacy but may also contribute to its higher side effect burden
First, it preserves muscle mass during rapid weight loss